Immunic Inc (NASDAQ: IMUX) started the day on Wednesday, with a price decrease of -9.19% at $0.98, before settling in for the price of $1.08 at the close. Taking a more long-term approach, IMUX posted a 52-week range of $0.95-$3.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 31.12%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 52.61%. This publicly-traded company’s shares outstanding now amounts to $90.08 million, simultaneously with a float of $85.28 million. The organization now has a market capitalization sitting at $88.34 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2337, while the 200-day Moving Average is $1.2701.
Immunic Inc (IMUX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Immunic Inc’s current insider ownership accounts for 5.33%, in contrast to 62.00% institutional ownership.
Immunic Inc (IMUX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/31/2024, the organization reported -0.54 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -0.52) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
Immunic Inc’s EPS increase for this current 12-month fiscal period is 52.61% and is forecasted to reach -0.85 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.50% through the next 5 years, which can be compared against the 31.12% growth it accomplished over the previous five years trading on the market.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Let’s observe the current performance indicators for Immunic Inc (IMUX). It’s Quick Ratio in the last reported quarter now stands at 5.09. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, IMUX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.84, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.85 at the market close of one year from today.
Technical Analysis of Immunic Inc (IMUX)
If we take a close look at the recent performances of Immunic Inc (NASDAQ: IMUX), its last 5-days Average volume was 0.34 million that shows plunge from its year to date volume of 0.63 million. During the previous 9 days, stock’s Stochastic %D was recorded 6.28% While, its Average True Range was 0.0706.
Raw Stochastic average of Immunic Inc (IMUX) in the period of the previous 100 days is set at 1.60%, which indicates a major fall in contrast to 2.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 48.84% that was lower than 61.52% volatility it exhibited in the past 100-days period.
